Ex vivo microfluidic technology dedicated to oncology
MISO Chip markets a microfluidic platform allowing the culture and ex vivo testing of human tumor samples. The company offers products and services for the research and development of drugs in oncology and develops a diagnostic test for the personalization of cancer treatments.
Here are the companies that are at the heart of each of our decisions and that we are proud to support.
Together, let’s build the world of tomorrow.
